Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Chemmedchem
|
July 8, 2026
Integrative Molecular Scaffold Generation of PI3K/mTOR Inhibitors Using DeepSARM and Ligand-Based Virtual Screening Approaches
Kenichiro Shimokawa, Yumi N Imai, Yasuyoshi Arikawa, et al.
Chemical & Pharmaceutical Bulletin
|
August 2, 2008
Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as selective adenosine A3 antagonists
Seiji Miwatashi, Yasuyoshi Arikawa, Tatsumi Matsumoto, et al.
Chemical & Pharmaceutical Bulletin
|
April 2, 2005
Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as p38 MAP kinase inhibitors
Seiji Miwatashi, Yasuyoshi Arikawa, Ken-Ichi Naruo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 14, 2010
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases
Yasunobu Hori, Akio Imanishi, Jun Matsukawa, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent
Seiji Miwatashi, Yasuyoshi Arikawa, Etsuo Kotani, et al.
Chemical & Pharmaceutical Bulletin
|
April 4, 2014
Molecular modeling, design, synthesis, and biological activity of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives as potassium-competitive acid blockers
Yasuyoshi Arikawa, Atsushi Hasuoka, Keizo Hirase, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 21, 2015
Synthetic studies of five-membered heteroaromatic derivatives as potassium-competitive acid blockers (P-CABs)
Yasuyoshi Arikawa, Atsushi Hasuoka, Haruyuki Nishida, et al.
Bioorganic & Medicinal Chemistry
|
May 15, 2012
Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers
Haruyuki Nishida, Atsushi Hasuoka, Yasuyoshi Arikawa, et al.
Bioorganic & Medicinal Chemistry
|
May 10, 2017
Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion
Haruyuki Nishida, Ikuo Fujimori, Yasuyoshi Arikawa, et al.
Journal of Medicinal Chemistry
|
April 20, 2012
Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB)
Yasuyoshi Arikawa, Haruyuki Nishida, Osamu Kurasawa, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Chemmedchem
|
July 8, 2026
Integrative Molecular Scaffold Generation of PI3K/mTOR Inhibitors Using DeepSARM and Ligand-Based Virtual Screening Approaches
Kenichiro Shimokawa, Yumi N Imai, Yasuyoshi Arikawa, et al.
Chemical & Pharmaceutical Bulletin
|
August 2, 2008
Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as selective adenosine A3 antagonists
Seiji Miwatashi, Yasuyoshi Arikawa, Tatsumi Matsumoto, et al.
Chemical & Pharmaceutical Bulletin
|
April 2, 2005
Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as p38 MAP kinase inhibitors
Seiji Miwatashi, Yasuyoshi Arikawa, Ken-Ichi Naruo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 14, 2010
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases
Yasunobu Hori, Akio Imanishi, Jun Matsukawa, et al.
Journal of Medicinal Chemistry
|
September 16, 2005
Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent
Seiji Miwatashi, Yasuyoshi Arikawa, Etsuo Kotani, et al.
Chemical & Pharmaceutical Bulletin
|
April 4, 2014
Molecular modeling, design, synthesis, and biological activity of 1H-pyrrolo[2,3-c]pyridine-7-amine derivatives as potassium-competitive acid blockers
Yasuyoshi Arikawa, Atsushi Hasuoka, Keizo Hirase, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 21, 2015
Synthetic studies of five-membered heteroaromatic derivatives as potassium-competitive acid blockers (P-CABs)
Yasuyoshi Arikawa, Atsushi Hasuoka, Haruyuki Nishida, et al.
Bioorganic & Medicinal Chemistry
|
May 15, 2012
Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers
Haruyuki Nishida, Atsushi Hasuoka, Yasuyoshi Arikawa, et al.
Bioorganic & Medicinal Chemistry
|
May 10, 2017
Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion
Haruyuki Nishida, Ikuo Fujimori, Yasuyoshi Arikawa, et al.
Journal of Medicinal Chemistry
|
April 20, 2012
Discovery of a novel pyrrole derivative 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB)
Yasuyoshi Arikawa, Haruyuki Nishida, Osamu Kurasawa, et al.
Page
of 2